Cargando…
Serum 25-Hydroxyvitamin D and Cancer Risk: A Systematic Review of Mendelian Randomization Studies
Epidemiological studies suggest that higher serum 25-hydroxyvitamin D is associated with lower risk for several cancers, including breast, prostate, colorectal, and lung cancers. To mitigate confounding, genetic instrumental variables (IVs) have been used to estimate causal associations between 25-h...
Autores principales: | Lawler, Thomas, Warren Andersen, Shaneda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865859/ https://www.ncbi.nlm.nih.gov/pubmed/36678292 http://dx.doi.org/10.3390/nu15020422 |
Ejemplares similares
-
Serum 25-Hydroxyvitamin D Concentrations and Major Depression: A Mendelian Randomization Study
por: Michaëlsson, Karl, et al.
Publicado: (2018) -
Serum Parathyroid Hormone, 25-Hydroxyvitamin D, and Risk of Alzheimer’s Disease: A Mendelian Randomization Study
por: Larsson, Susanna C., et al.
Publicado: (2018) -
Genetic Variants, Serum 25-Hydroxyvitamin D Levels, and Sarcopenia: A Mendelian Randomization Analysis
por: Sha, Tingting, et al.
Publicado: (2023) -
Serum calcium and 25-hydroxyvitamin D in relation to longevity, cardiovascular disease and cancer: a Mendelian randomization study
por: Yuan, Shuai, et al.
Publicado: (2021) -
Assessing the causal association between 25‐hydroxyvitamin D and the risk of oral and oropharyngeal cancer using Mendelian randomization
por: Dudding, Tom, et al.
Publicado: (2018)